Log in
Enquire now
Biofire Diagnostics

Biofire Diagnostics

A biotechnology company that detects pathogens and mutations to diagnose syndromic infectious disease

OverviewStructured DataIssuesContributorsActivity

Contents

COVID-19TimelineTable: Funding RoundsTable: ProductsTable: AcquisitionsTable: SBIR/STTR AwardsTable: PatentsTable: Further ResourcesReferences
biofiredx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Consumer biotechnology
Consumer biotechnology
Medical diagnostics
Medical diagnostics
Loading...
Biomedical engineering
Biomedical engineering
Molecular biology
Molecular biology
Molecular diagnostics
Molecular diagnostics
Technology
Technology
Biology
Biology
...
Location
Salt Lake City
Salt Lake City
B2X
B2B
B2B
CEO
‌
Kirk Ririe
Founder
‌
Carl Wittwer
‌
Randy Rasmussen
AngelList URL
angel.co/biofire-diagnostics
Pitchbook URL
pitchbook.com/profiles.../55275-31
Legal Name
BioFire Diagnostics, LLC.
Parent Organization
bioMerieux
bioMerieux
Number of Employees (Ranges)
1,001 – 5,0004
Email Address
support@biofiredx.com
Full Address
515 Colorow Drive, Salt Lake City, Utah 84108, US
Investors
Athyrium Capital Management, LP
Athyrium Capital Management, LP
Founded Date
1990
4
Total Funding Amount (USD)
25,000,000
Latest Funding Round Date
September 19, 2012
Glassdoor ID
650435
Patents Assigned (Count)
12
Wellfound ID
biofire-diagnostics
Country
United States
United States

Other attributes

Company Operating Status
Active
Wikidata ID
Q30282789

Biofire Diagnostics, LLC is a biotechnology company that provides syndromic infectious disease diagnostic services. The Salt Lake City-based company was founded in 1990. In 2013, the company was acquired by France-based biotechnology and health diagnostics company BioMérieux, becoming BioMérieux’s Global Center of Excellence for Molecular Diagnostics.

Biofire produced the BioFire FilmArray System for comprehensive multiplex PCR testing. The FDA-cleared BioFire System panels test for viruses, bacteria, parasites, yeast, and antimicrobial resistance genes. The company has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research and military markets. For many pathogens, Biofire has both FDA-cleared and CE-IVD marked assays.

COVID-19

In collaboration with the Department of Defense, BioFire Defense has developed a fully-automated, sample-to-result assay for the specific detection of SARS-CoV-2, the causative agent of COVID-19. The test has been authorized by the FDA under Emergency Use Authorization (EUA). This assay is designed to run on both the BioFire FilmArray 2.0 and BioFire FilmArray Torch Systems, delivering results in about 45 minutes. After meeting initial DoD demand, commercial availability under EUA is anticipated in April of 2020.

In parallel, BioFire Diagnostics is developing new SARS-CoV-2-specific assays for addition to the BioFire FilmArray Respiratory 2 (RP2) Panel. This new panel is named the BioFire Respiratory 2.1 (RP2.1) Panel and is being developed for both the BioFire 2.0 and BioFire Torch Systems. In addition to the detection of SARS-CoV-2, the BioFire RP2.1 Panel will detect 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness in about 45 minutes. Development of the BioFire RP2.1 Panel is occurring on an accelerated timeline, and submission to the FDA for EUA and 510(k) clearance is anticipated in Q3 of 2020.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Theranos patents at center of lawsuit over startup's COVID-19 tests - Business Insider

Aaron Holmes

https://www.businessinsider.com/theranos-patents-fortress-labrador-diagnostics-lawsuit-biofire-coronavirus-tests-2020-3

Web

March 17, 2020

References

Find more companies like Biofire Diagnostics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.